Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1666884

This article is part of the Research TopicThe Role of Innate Immunity in the Pathogenesis of Autoimmune and Autoinflammatory DiseasesView all 5 articles

Neutrophil-to-Albumin Ratio (NPAR): A Novel Predictor of Osteoporosis in Rheumatoid Arthritis

Provisionally accepted
Yifang  ZHANGYifang ZHANG1*Zhongyv  HEZhongyv HE1Kaiqiang  LIKaiqiang LI1Qiuping  WUQiuping WU1Shigang  WANGShigang WANG1Minying  LIUMinying LIU2Qing-Ping  LiuQing-Ping Liu2Qiang  XuQiang Xu2*Xiangying  KongXiangying Kong3*Changsong  LINChangsong LIN2*
  • 1First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
  • 2Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, China
  • 3China Academy of Chinese Medical Sciences, Beijing, China

The final, formatted version of the article will be published soon.

Background: Osteoporosis (OP) frequently coexists with rheumatoid arthritis (RA), but validated predictors of early risk are not extensively studied. This study seeks to examine the relationship between the neutrophil percentage-to-albumin ratio (NPAR) and the likelihood of developing RA-related OP(RA-OP). Methods: After investigating the relationship between the NPAR and RA-OP in the clinical retrospective study, we further validated this association using data from the National Health and Nutrition Examination Survey (NHANES) database (2005-2020 cycles). This retrospective study enrolled 718 RA patients from the Rheumatology Department of the First Affiliated Hospital of Guangzhou University of Chinese Medicine between January 2020 and December 2024. Patients were categorized into low-NPAR (<1.7598) and high-NPAR (≥1.7598) groups based on the median NPAR. Extracted clinical data encompassed demographic characteristics, comorbidities, serological markers, and other laboratory parameters. Preliminary univariate and multivariate logistic regression analyses assessed potential associations between NPAR and RA-OP, multi-model adjusted logistic regression was subsequently applied to evaluate the independent association, subgroup analyses examined consistency across demographic and clinical strata, Receiver operating characteristic (ROC) curve analysis assessed NPAR's diagnostic performance, and then Restricted cubic splines (RCS) visualized potential non-linear relationships. Finally using the identical statistical framework, we validated findings within the NHANES cohort. Results: The high-NPAR group exhibited significantly higher OP incidence than the low-NPAR group (39.0% vs. 26.5%; P<0.001). After full adjustment (Model 4), NPAR remained independently associated with increased RA-OP risk as a categorical variable (high vs. low NPAR: adjusted OR=1.70 (95%CI: 1.01~2.88); P=0.049). Subgroup analyses demonstrated no significant interaction effects (P-interaction>0.05) except for disease duration. The ROC curve showed an Area Under the Curve(AUC) of 0.58 (95%CI: 0.53~0.63) and NPAR cut-off of 1.886. The covariate-adjusted RCS indicated a linear dose-response relationship (P overall=0.033; P nonlinearity=0.168). NHANES cohort analysis independently validated both the NPAR-RA-OP association and its linear characteristic. Conclusion: NPAR, serving as a novel composite biomarker integrating neutrophil-mediated inflammation and nutritional status (via albumin), independently predicts OP risk in RA. Its derivation from routine clinical parameters renders NPAR a readily deployable, cost-effective tool for OP risk stratification in clinical practice.

Keywords: Rheumatoid arthritis, Osteoporosis, Neutrophil percentage to albumin ratio, Inflammation, National Health and Nutrition Examination Survey, risk stratification

Received: 16 Jul 2025; Accepted: 31 Aug 2025.

Copyright: © 2025 ZHANG, HE, LI, WU, WANG, LIU, Liu, Xu, Kong and LIN. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yifang ZHANG, First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
Qiang Xu, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, China
Xiangying Kong, China Academy of Chinese Medical Sciences, Beijing, China
Changsong LIN, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.